Inflammatory biomarkers in Alzheimer's disease plasma

Magda Tsolaki | Edward T. Bullmore | Gareth J. Barker | Frederik Barkhof | B. Paul Morgan | Guy B. Williams | Mara Cercignani | José Luis Molinuevo | Richard Reynolds | Federico Turkheimer | Alejo Nevado-Holgado | Philip Scheltens | Jonathan Cavanagh | Scott Farmer | Henrik Zetterberg | Manfred G. Kitzbichler | Tobias C. Wood | Patrizia Mecocci | Lars Bertram | Mary-Ellen Lynall | Karen H. Adams | Pablo Martinez-Lage | Stuart Clare | Thomas Möller | Peter Johannsen | Giovanni Frisoni | Simon Lovestone | Karen Meersmans | Alberto Lleó | Neil A. Harrison | Hans Eriksson | Wayne C. Drevets | Lars-Olof Wahlund | Diana Cash | Nisha Singh | Pieter Jelle Visser | Rik Vandenberghe | Johannes Streffer | Junaid Bhatti | Olivier Blin | Gayle Wittenberg | Sebastiaan Engelborghs | Lutz Frölich | Carmine M. Pariante | Cristina Legido-Quigley | Marta M. Correia | Madeleine Cleal | Annamaria Cattaneo | Charlotte Teunissen | Isabelle Bos | Valeria Mondelli | E. Bullmore | F. Turkheimer | B. Widmer | P. Vértes | J. Molinuevo | P. Scheltens | O. Blin | M. Lynall | M. Kitzbichler | F. Barkhof | W. Drevets | G. Frisoni | S. Clare | P. Visser | C. Pariante | P. Mecocci | M. Tsolaki | I. Kloszewska | S. Lovestone | L. Wahlund | A. Wallin | S. Engelborghs | N. Harrison | R. Vandenberghe | A. Morgan | M. Cercignani | P. Johannsen | R. Balice-Gordon | L. Frölich | J. Streffer | L. Bertram | G. Barker | A. Lleó | J. Richardson | R. Mancuso | D. Gomez-Nicola | H. Zetterberg | P. Kettunen | L. Pointon | A. Bhattacharya | A. Nevado-Holgado | M. Correia | A. Cattaneo | N. Mariani | V. Mondelli | J. Duerr | C. Legido-Quigley | F. Gastambide | T. Möller | Madeleine Cleal | G. Wittenberg | Shahid Khan | J. Cavanagh | S. Westwood | M. Nettis | H. Kolb | N. Plath | D. Cash | V. Perry | Dominika Wlazły | P. de Boer | M. Attenburrow | P. Martínez-Lage | E. Ribe | A. Baird | I. Bos | S. Vos | J. Popp | V. Dobričić | Samuel Touchard | C. O’Hagan | R. Reynolds | C. Parker | Nisha Singh | Karen Meersmans | Diego Gomez-Nicola | V. Hugh Perry | Jeffrey S. Nye | Anders Wallin | J. Nye | M. Vicente-Rodríguez | Philip Cowen | Jill Richardson | Sarah Westwood | Alison Baird | Petronella Kettunen | Gwendoline Peyratout | Valerija Dobricic | Julius Popp | Alejo J. Nevado-Holgado | Isabel Sala | J. Egebjerg | Antony Gee | C. Simmons | Isabel Sala | Anindya Bhattacharya | Jill C. Richardson | Iwona Kłoszewska | Christian Thomsen | Stephanie Vos | Rita Balice-Gordon | Hikka Soininen | Niels Plath | Angharad R. Morgan | Andrew McPherson | Renzo Mancuso | Gemma Fryatt | Elena Ribe | Marta Vicente-Rodriguez | Camilla Simmons | Amber Dickinson | Clare Knight | Christina Maurice | Ciara O'Donnell | Lorinda Turner | Petra Vertes | Barry Widmer | Caroline O'Hagan | Samuel Touchard | Catherine Deith | John McClean | Alison McColl | Paul Scouller | Murray Sutherland | Shahid Khan | Phil Murphy | Jai Patel | Declan Jones | Peter de Boer | John Kemp | John Isaac | Nick Carruthers | Hartmuth Kolb | Heidi Byrom | Caitlin Hastings | Nicole Mariani | Anna McLaughlin | Maria Nettis | Naghmeh Nikkheslat | Karen Randall | Hannah Sheridan | Courtney Worrell | Zuzanna Zajkowska | Jan Egebjerg | Francois Gastambide | Karen Husted Adams | Ross Jeggo | Jan Torleif Pederson | Brian Campbell | Bob Nelson | Stevin Zorn | Jason O'Connor | Mary Jane Attenburrow | Jithen Benjamin | I-Shu (Dante) Huang | Samuel Hurley | Helen Jones | Francisca Mada | Akintayo Oladejo | Katy Smith | Anviti Vyas | Zoe Hughes | James Duerr | Jonathan Sporn | Charlotte L Clarke | Elizabeth Hoskins | Charmaine Kohn | Rosemary Murray | Lauren Wilcock | Dominika Wlazly | Howard Mount | Gemma L. Fryatt | Junaid Bhatti | Samuel J. Chamberlain | Anna L. Crofts | A. Dickinson | Clare Knight | Christina Maurice | Ciara O’Donnell | L. Turner | C. Leckey | Catherine Deith | Scott J. Farmer | A. McColl | Paul Scouller | Murray Sutherland | H. Boddeke | Phil Murphy | Declan Jones | J. Kemp | Nick Carruthers | H. Byrom | C. Hastings | A. McLaughlin | N. Nikkheslat | K. Randall | Hannah Sheridan | C. Worrell | Z. Zajkowska | R. Jeggo | J. Pederson | Bob Nelson | Jithen Benjamin | Helen Jones | Francisca Mada | Akintayo Oladejo | Katy Smith | Anviti Vyas | Zoe Hughes | Justin R. Piro | J. Sporn | E. Hoskins | Lauren Wilcock | Christine A. Parker | Claire Leckey | Silvey Gabel | Mikel Tainta-Cuezva | Edward T. Junaid Samuel J. Marta M. Anna L. Amber Andrew Bullmore Bhatti Chamberlain Correia Crofts | Andrew C. Foster | Linda J. Pointon | Peter St George Hyslop | Claire A. Leckey | H.W.G.M. Boddeke | Victoria Van Loo | Charlotte L. Clarke | Philip A. Cowen | P. St. George Hyslop | A. Foster | Sam Hurley | C. Kohn | G. Peyratout | J. Isaac | C. Teunissen | H. Soininen | Rosemary Murray | Andrew McPherson | Silvey Gabel | Mikel Tainta-Cuezva | B. Morgan | B. P. Morgan | J. Mcclean | Jai Patel | Antony Gee | V. Van Loo | Hans Eriksson | C. Thomsen | B. Campbell | T. Möller | Stevin Zorn | Jason O’Connor | H. Mount | A. Mccoll | N. Carruthers | Antony D. Gee | Samuel Touchard | Claire Leckey | Caroline O'Hagan | Claire A. Leckey | Victoria Van Loo | I. Huang | H. Eriksson | Christian Thomsen | Simon Lovestone | Jill C. Richardson | Angharad R. Morgan | B. P. Morgan | Richard Reynolds | V. Dobricic

[1]  A. Bayer.  The role of biomarkers and imaging in the clinical diagnosis of dementia , 2018, Age and ageing.

[2]  R. Dobson,et al.  The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics , 2018, Alzheimer's Research & Therapy.

[3]  M. Chupin,et al.  Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers , 2018, Alzheimer's & Dementia.

[4]  K. Blennow,et al.  From Cerebrospinal Fluid to Blood: The Third Wave of Fluid Biomarkers for Alzheimer's Disease. , 2018, Journal of Alzheimer's disease : JAD.

[5]  C. Rowe,et al.  High performance plasma amyloid-β biomarkers for Alzheimer’s disease , 2018, Nature.

[6]  J. Hanson,et al.  Microglia in Alzheimer’s disease , 2018, The Journal of cell biology.

[7]  B. Morgan,et al.  Complement in the pathogenesis of Alzheimer’s disease , 2017, Seminars in Immunopathology.

[8]  S. Lovestone,et al.  Effects of freezer storage time on levels of complement biomarkers , 2017, BMC Research Notes.

[9]  C. Ritchie,et al.  CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). , 2017, The Cochrane database of systematic reviews.

[10]  R. Sims,et al.  The Correlation between Inflammatory Biomarkers and Polygenic Risk Score in Alzheimer's Disease. , 2017, Journal of Alzheimer's disease : JAD.

[11]  J. Rogers,et al.  Inflammation, Antiinflammatory Agents, and Alzheimer's Disease: The Last 22 Years. , 2016, Journal of Alzheimer's disease : JAD.

[12]  R. Dobson,et al.  Complement Biomarkers as Predictors of Disease Progression in Alzheimer's Disease. , 2016, Journal of Alzheimer's disease : JAD.

[13]  J. Kramer,et al.  MCP-1 and eotaxin-1 selectively and negatively associate with memory in MCI and Alzheimer's disease dementia phenotypes , 2016, Alzheimer's & dementia.

[14]  K. Blennow,et al.  Plasma β-amyloid in Alzheimer’s disease and vascular disease , 2016, Scientific Reports.

[15]  Fuhai Song,et al.  Perturbation of the transcriptome: implications of the innate immune system in Alzheimer's disease. , 2016, Current opinion in pharmacology.

[16]  S. Lovestone,et al.  Blood-Based Proteomic Biomarkers of Alzheimer’s Disease Pathology , 2015, Front. Neurol..

[17]  B. Paul Morgan,et al.  Complement, a target for therapy in inflammatory and degenerative diseases , 2015, Nature Reviews Drug Discovery.

[18]  A. Lucia,et al.  Non-Steroidal Anti-Inflammatory Drugs as a Treatment for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Treatment Effect , 2015, Drugs & Aging.

[19]  J. Gallacher,et al.  Convergent genetic and expression data implicate immunity in Alzheimer's disease , 2014, Alzheimer's & Dementia.

[20]  D. Craig,et al.  Plasma Complement factor H in Alzheimer's Disease. , 2015, Journal of Alzheimer's disease : JAD.

[21]  L. Tan,et al.  Anti-inflammatory drugs and risk of Alzheimer's disease: an updated systematic review and meta-analysis. , 2015, Journal of Alzheimer's disease : JAD.

[22]  Magda Tsolaki,et al.  Plasma proteins predict conversion to dementia from prodromal disease , 2014, Alzheimer's & Dementia.

[23]  Magda Tsolaki,et al.  Candidate blood proteome markers of Alzheimer's disease onset and progression: a systematic review and replication study. , 2013, Journal of Alzheimer's disease : JAD.

[24]  Hilkka Soininen,et al.  Prognostic polypeptide blood plasma biomarkers of Alzheimer's disease progression. , 2014, Journal of Alzheimer's disease : JAD.

[25]  Michael S. McGrath,et al.  Systemic immune system alterations in early stages of Alzheimer's disease , 2013, Journal of Neuroimmunology.

[26]  F. Jessen,et al.  The AD-CSF-index discriminates Alzheimer's disease patients from healthy controls: a validation study. , 2013, Journal of Alzheimer's disease : JAD.

[27]  H. Gürvit,et al.  BDNF, TNFα, HSP90, CFH, and IL-10 serum levels in patients with early or late onset Alzheimer's disease or mild cognitive impairment. , 2013, Journal of Alzheimer's disease : JAD.

[28]  S. Lovestone,et al.  Plasma biomarkers for Alzheimer's disease: much needed but tough to find. , 2012, Biomarkers in medicine.

[29]  K. Blennow,et al.  Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer’s disease , 2012, Journal of Neural Transmission.

[30]  Michelle K. Lupton,et al.  Complement activation as a biomarker for Alzheimer's disease. , 2012, Immunobiology.

[31]  P. Caramelli,et al.  Chemokines in CSF of Alzheimer's disease patients. , 2011, Arquivos de neuro-psiquiatria.

[32]  Seth Love,et al.  Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease , 2010, PloS one.

[33]  Simon Heath,et al.  Implication of the immune system in Alzheimer's disease: evidence from genome-wide pathway analysis. , 2010, Journal of Alzheimer's disease : JAD.

[34]  L. Kiemeney,et al.  Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer , 2009, Nature Genetics.

[35]  A. Simmons,et al.  AddNeuroMed—The European Collaboration for the Discovery of Novel Biomarkers for Alzheimer's Disease , 2009, Annals of the New York Academy of Sciences.

[36]  A. Simmons,et al.  MRI Measures of Alzheimer's Disease and the AddNeuroMed Study , 2009, Annals of the New York Academy of Sciences.

[37]  P. Sachdev,et al.  Plasma biomarkers for mild cognitive impairment and Alzheimer's disease , 2009, Brain Research Reviews.

[38]  Nick C Fox,et al.  Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes , 2009, Nature Genetics.

[39]  Nick C Fox,et al.  Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease , 2009 .

[40]  Sandra Mandic,et al.  Relationship of Predictive Modeling to Receiver Operating Characteristics , 2008, Journal of cardiopulmonary rehabilitation and prevention.

[41]  Chulhee Choi,et al.  Multiplex Analysis of Cytokines in the Serum and Cerebrospinal Fluid of Patients With Alzheimer's Disease by Color-Coded Bead Technology , 2008, Journal of clinical neurology.

[42]  F. Stivala,et al.  Altered plasma cytokine levels in Alzheimer's disease: correlation with the disease progression. , 2007, Immunology letters.

[43]  R. Tibshirani,et al.  Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins , 2007, Nature Medicine.

[44]  N. Bresolin,et al.  Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease , 2006, Neurobiology of Aging.

[45]  S. Lovestone,et al.  Proteome-based plasma biomarkers for Alzheimer's disease. , 2006, Brain : a journal of neurology.

[46]  N. Bresolin,et al.  Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease. , 2006, Archives of neurology.

[47]  Farzaneh A. Sorond,et al.  Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis , 2005, The Lancet Neurology.

[48]  R. Petersen.  Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.

[49]  A. Hofman,et al.  Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. , 2004, Archives of neurology.

[50]  M. Etminan,et al.  Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies , 2003, BMJ : British Medical Journal.

[51]  P. Scheltens,et al.  Chemokines in serum and cerebrospinal fluid of Alzheimer's disease patients , 2003, Annals of neurology.

[52]  F. Itoh,et al.  Association between complement regulatory protein factor H and AM34 antigen, detected in senile plaques. , 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.

[53]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.